USPTO Biotech/Chemical Partnership (BCP) Meetings

BCP meetings are part of a long-standing partnership between the USPTO and our valued stakeholders that works to improve the quality of our products and services. The meeting’s discussion topics include:

• Prior art in a litigation world
• After final practice and request for continued examination
• Using Food and Drug Administration and National Institutes of Health databases to search drugs, formulations and their methods of use
• Enablement in the chemical arts

Please note: The slides from each speaker are provided here as a convenience but do not necessarily represent the views of the USPTO.

Agenda

11:00 a.m. - 11:05 a.m. 

Welcome and Opening Remarks

• Patricia Mallari, Director, TC 1600, USPTO

11:05 a.m. - 12:05 p.m.

Artificial Intelligence (Al) Guidance Updates

• Nalini Mummalaneni, Senior Legal Advisor, Office of Patent Legal Administration, USPTO

12:05 - 12:30 a.m.

• Break

12:30 - 1:30 p.m.

Machine Learning Use Cases and Example Model Types

• David Raczkowski, Ph.D., Partner, Kilpatrick Townsend & Stockton LLP

1:30 - 2:30 p.m.

Artificial Intelligence and Subject Matter Eligibility Under §101: Trends and Best Practices

• Ernest J. Beffel Jr., Partner, Haynes Beffel & Wolfeld LLP

2:30 p.m. - 3:00 p.m.

AI in Biotechnology: An analysis of USPTO patent applications, 2002-2023

• Nicholas A. Pairolero, Ph.D., Senior Research Economist, Office of the Chief Economist, UPSTO
• Hannah Powell, Ph.D., Patent Engineer, Haynes Beffel & Wolfeld LLP

3:00 p.m. - 3:05 p.m.

Closing remarks

• Daniel Sullivan, Director, TC 1600 USPTO